相似文献
1
Seeing through VEGF: innate and adaptive immunity in pathological angiogenesis in the eye.
Trends Mol Med. 2015 Jan;21(1):43-51. doi: 10.1016/j.molmed.2014.10.005. Epub 2014 Nov 1.
2
Anti-vascular endothelial growth factor therapy for ocular neovascular disease.
Curr Opin Ophthalmol. 2007 Nov;18(6):502-8. doi: 10.1097/ICU.0b013e3282f0ca54.
3
Vascular endothelial growth factors and angiogenesis in eye disease.
Prog Retin Eye Res. 2003 Jan;22(1):1-29. doi: 10.1016/s1350-9462(02)00043-5.
4
Gene Therapy Intervention in Neovascular Eye Disease: A Recent Update.
Mol Ther. 2020 Oct 7;28(10):2120-2138. doi: 10.1016/j.ymthe.2020.06.029. Epub 2020 Jun 30.
5
Current molecular understanding and future treatment strategies for pathologic ocular neovascularization.
Curr Mol Med. 2009 Nov;9(8):973-81. doi: 10.2174/156652409789712783.
6
Interaction of angiogenic and immune mechanisms in the eye.
Semin Ophthalmol. 2006 Jan-Mar;21(1):37-40. doi: 10.1080/08820530500509424.
7
Anti-vascular endothelial growth factor therapy for neovascular ocular diseases other than age-related macular degeneration.
Curr Opin Ophthalmol. 2009 May;20(3):166-74. doi: 10.1097/ICU.0b013e328329d173.
8
Interleukin-17: The Role for Pathological Angiogenesis in Ocular Neovascular Diseases.
Tohoku J Exp Med. 2019 Feb;247(2):87-98. doi: 10.1620/tjem.247.87.
9
Molecular Basis of Angiogenesis and its Application.
Keio J Med. 2024;73(1):12. doi: 10.2302/kjm.ABSTRACT_73_1-1.
10
Preclinical and phase 1A clinical evaluation of an anti-VEGF pegylated aptamer (EYE001) for the treatment of exudative age-related macular degeneration.
Retina. 2002 Apr;22(2):143-52. doi: 10.1097/00006982-200204000-00002.
引用本文的文献
1
Phlorizin Protects Against Oxidative Stress and Inflammation in Age-Related Macular Degeneration Model.
Biomolecules. 2025 Apr 3;15(4):523. doi: 10.3390/biom15040523.
2
Spatial transcriptomics reveals regionally altered gene expression that drives retinal degeneration.
Commun Biol. 2025 Apr 18;8(1):629. doi: 10.1038/s42003-025-07887-2.
3
Protective effects of carotenoids against blue light induced-cellular damage in human retinal pigment epithelium.
Food Sci Biotechnol. 2025 Jan 27;34(8):1713-1723. doi: 10.1007/s10068-024-01757-z. eCollection 2025 Apr.
4
The Landscape of Vascular Endothelial Growth Factor Inhibition in Retinal Diseases.
Invest Ophthalmol Vis Sci. 2025 Jan 2;66(1):47. doi: 10.1167/iovs.66.1.47.
5
The immunological perspective of major depressive disorder: unveiling the interactions between central and peripheral immune mechanisms.
J Neuroinflammation. 2025 Jan 19;22(1):10. doi: 10.1186/s12974-024-03312-3.
6
Macrophage metabolic reprogramming ameliorates diabetes-induced microvascular dysfunction.
Redox Biol. 2025 Feb;79:103449. doi: 10.1016/j.redox.2024.103449. Epub 2024 Nov 29.
7
Complement regulation in the eye: implications for age-related macular degeneration.
J Clin Invest. 2024 May 1;134(9):e178296. doi: 10.1172/JCI178296.
8
Cell-specific Systemic Immune Signatures Associated with Treatment Burden in Neovascular Age-related Macular Degeneration.
Ophthalmol Sci. 2023 Oct 11;4(2):100410. doi: 10.1016/j.xops.2023.100410. eCollection 2024 Mar-Apr.
9
Retinal detachment.
Nat Rev Dis Primers. 2024 Mar 14;10(1):18. doi: 10.1038/s41572-024-00501-5.
10
Transfer RNA derived fragment, tRF-Glu-CTC, aggravates the development of neovascular age-related macular degeneration.
Theranostics. 2024 Jan 27;14(4):1500-1516. doi: 10.7150/thno.92943. eCollection 2024.
本文引用的文献
1
Molecular mechanisms of diabetic retinopathy, general preventive strategies, and novel therapeutic targets.
Biomed Res Int. 2014;2014:801269. doi: 10.1155/2014/801269. Epub 2014 Jul 6.
2
Macrophage activation and polarization: nomenclature and experimental guidelines.
Immunity. 2014 Jul 17;41(1):14-20. doi: 10.1016/j.immuni.2014.06.008.
3
Potential Sources and Roles of Adaptive Immunity in Age-Related Macular Degeneration: Shall We Rename AMD into Autoimmune Macular Disease?
Autoimmune Dis. 2014;2014:532487. doi: 10.1155/2014/532487. Epub 2014 Apr 30.
4
VEGF-A promotes both pro-angiogenic and neurotrophic capacities for nerve recovery after compressive neuropathy in rats.
Mol Neurobiol. 2015 Feb;51(1):240-51. doi: 10.1007/s12035-014-8754-1. Epub 2014 May 28.
5
Imatinib inhibits VEGF-independent angiogenesis by targeting neuropilin 1-dependent ABL1 activation in endothelial cells.
J Exp Med. 2014 Jun 2;211(6):1167-83. doi: 10.1084/jem.20132330. Epub 2014 May 26.
6
Immune responses in age-related macular degeneration and a possible long-term therapeutic strategy for prevention.
Am J Ophthalmol. 2014 Jul;158(1):5-11.e2. doi: 10.1016/j.ajo.2014.03.014. Epub 2014 Apr 4.
7
Neuronal cell death in the inner retina and the influence of vascular endothelial growth factor inhibition in a diabetic rat model.
Am J Pathol. 2014 Jun;184(6):1752-62. doi: 10.1016/j.ajpath.2014.02.016. Epub 2014 Apr 5.
8
The M1 and M2 paradigm of macrophage activation: time for reassessment.
F1000Prime Rep. 2014 Mar 3;6:13. doi: 10.12703/P6-13. eCollection 2014.
9
The alternative complement pathway regulates pathological angiogenesis in the retina.
FASEB J. 2014 Jul;28(7):3171-82. doi: 10.1096/fj.14-251041. Epub 2014 Mar 25.
10
Role of endothelial cell and pericyte dysfunction in diabetic retinopathy: review of techniques in rodent models.
Adv Exp Med Biol. 2014;801:669-75. doi: 10.1007/978-1-4614-3209-8_84.
Zotero 插件